跳到正文
原文
Nature 健康护理主题·· 2026-10-05AI 评分40

5.0 μm 在线静脉过滤器用于外科住院患者的成本效果:基于决策树与 Markov 模型

Cost-effectiveness of 5.0 μm inline intravenous filtration in surgical inpatients using a decision tree and Markov model

AI 导读

决策树与 Markov 模型显示,5.0 μm 在线静脉过滤器用于外科住院患者,在 2 年、5 年和 60 年时间范围内均为优势策略,可节省成本并提高 QALYs。研究基于三级医院电子病历的回顾性队列数据,将静脉炎发生率下降作为外部模型输入,假设过滤器可降低静脉炎发生。确定性与概率敏感性分析支持结果稳健,作者认为可为过滤器标准化使用和报销决策提供依据。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Phlebitis is a common complication of intravenous (IV) therapy, especially in vulnerable populations such as surgical inpatients. Despite being frequently overlooked due to its typically mild presentation, phlebitis may lead to severe complications in high-risk patients. This study aimed to evaluate the clinical effectiveness and cost-effectiveness of 5.0 μm inline filters in reducing phlebitis and associated outcomes. We conducted a retrospective cohort study using electronic medical record (EMR) data from a tertiary hospital. The reduction in phlebitis incidence was incorporated as an externally derived model input, informed by published literature and SCRAP-based relative reduction after routine filter adoption. A decision tree and Markov model were developed to evaluate cost-effectiveness over 2-year, 5-year, and 60-year horizons, from the healthcare provider perspective. Cost inputs were derived from real-world clinical and financial data, while transition probabilities were derived from published literature, SCRAP data, and explicit model assumptions. Outcomes were expressed in costs, QALYs, and incremental cost-effectiveness ratios (ICERs), with both deterministic and probabilistic sensitivity analyses conducted. Based on previously reported evidence, inline filters are assumed to reduce the incidence of phlebitis, particularly in high-risk populations. Our model showed that implementing inline filters is a dominant strategy across all time horizons, leading to both cost savings and improved QALYs. The largest cost benefits were observed in the early years of use. Sensitivity analyses, including one-way, two-way, and probabilistic simulations, confirmed the robustness of the results across key clinical and economic parameters. Inline filtration may provide modest economic benefits through reductions in infusion-related complications, particularly in high-risk surgical inpatients. These findings support the broader implementation of inline filtration as a quality improvement strategy and infection control measure. The results also provide timely evidence to guide policy recommendations and reimbursement decisions regarding standardizing filter use.

Funding

This research was supported by Medi Line Active Korea. The funder had no role in the study design, model structure, parameter selection, data analysis, interpretation of results, or manuscript preparation.

Author information

Authors and Affiliations

  1. Department of Biohealth Industry, Graduate School of Transdisciplinary Health Sciences, Yonsei University, Seoul, Republic of Korea

    KyungYi Kim & Tae Hyun Kim

  2. Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea

    JinWook Lee

  3. Gangnam Severance Hospital, Seoul, Republic of Korea

    Se Hee Park

  4. Department of Preventive Medicine, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea

    Sang Gyu Lee

Authors

  1. KyungYi Kim
  2. JinWook Lee
  3. Se Hee Park
  4. Tae Hyun Kim
  5. Sang Gyu Lee

Corresponding author

Correspondence to Sang Gyu Lee.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, K., Lee, J., Park, S.H. et al. Cost-effectiveness of 5.0 μm inline intravenous filtration in surgical inpatients using a decision tree and Markov model. Sci Rep (2026). https://doi.org/10.1038/s41598-026-73766-3

Download citation

  • Received: 22 August 2025

  • Accepted: 24 September 2026

  • Published: 05 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-73766-3

Keywords

来源:Nature 健康护理主题 · nature.com